Skip to main content

Table 1 Patient characteristics

From: Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379]

  Placebo starter GBP starter   
    Excluded from analysis  
    Placebo starter GBP starter
  N = 24 N = 22 N = 5 N = 7
Sex (F/M) 21/4 18/4 3/2 6/1
Age in years 42 (± 13) 47 (± 14) 40 (± 11) 43 (± 11)
Duration in months 43 (± 36) 44 (± 21) 83 (± 39) 45 (± 30)
VAS0 64.2 (± 16) 62.5 (± 18) 62 (± 10) 67 (± 12)
VAS2 67 (± 20) 64(± 21)   
Upper extremity in pain 3R 8L 3RL = 14 8R 7L 4RL = 18 2R 0L 1RL 2R 4L 0RL
Lower extremity in pain 2R 7L 4RL = 13 3R 3L 0RL = 6 2R 1L 0RL 1R 1L 1RL
  1. R/L/RL represents no. of patients that report pain in resp. right, left or bilateral extremities.
  2. A few patients had upper and lower extremity pain. VAS is pain level on visual analogue scale. VAS0 is day 1, VAS2 is day 21 (post wash-out). Data are mean with (SD)